
CAS 256948-32-0
:Formula:C24H40N4O6S2
InChI:InChI=1S/2C10H18N2OS.C4H4O4/c2*1-12(2)7-9-3-4-10(13-9)8-14-6-5-11;5-3(6)1-2-4(7)8/h2*3-4H,5-8,11H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+
InChI key:UZQUECKZJOVTLJ-WXXKFALUSA-N
SMILES:CN(C)CC1=CC=C(O1)CSCCN.CN(C)CC1=CC=C(O1)CSCCN.C(=C/C(=O)O)\C(=O)O
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Ranitidine Related Compound A
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C10H18N2OSC4H4O4Color and Shape:Off-White Crystalline PowderMolecular weight:272.362-[[[5-[(Dimethylamino)methyl]furan-2-yl]methyl]sulfanyl]ethanamine Hemifumarate
CAS:Controlled ProductFormula:C10H18N2OS·C4H4O4Color and Shape:NeatMolecular weight:544.72762-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethanamine Fumarate (2:1)
CAS:Controlled ProductImpurity USP Ranitidine Related Compound A
Applications 2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethanamine (E)-2-Butenedioate is an impurity of Ranitidine (R120000), a histamine H2-receptor antagonist which inhibits gastric acid secretion. Antiulcerative.
References Bradshaw, J., et al.: Brit. J. Pharmacol., 66, 464 (1979), Berstad, A., et al.: Scand. J. Gastroenterol, 15, 637 (1980), Hohnjec, M., et al.: Anal. Profiles Drug Subs., 15, 533 (1986),Formula:C10H18N2OS·C4H4O4Color and Shape:NeatMolecular weight:544.7276[[5-[[(2-Aminoethyl)thio]methyl]furan-2-yl]methyl]dimethylamine, hemifumarate
CAS:Ai Product Descriptions 50 CreativeFormula:C10H18N2OS·2C4H4O4Purity:Min. 95%Molecular weight:446.47 g/mol




